(TheNewswire)
Calgary, Alberta – TheNewswire - April 24,2024 – nDatalyze Corp.( “ NDAT ” or the “ Corporation”) (CSE:NDAT) (OTC:NDATF) is pleasedto announce it has closed its previously-announced private placement( “ PP ”) of 1,000,000common shares ( “ Shares ”) at US$0.15 per Share (US$150,000) to asingle US accredited investor. At a 1.375 exchange rate this equatesto approximately $206,250 Canadian Dollars and approximately $0.21 perShare subscription price. A 6% finders fee of US$9,000 will be paid incash to a third party and 90% of the net proceeds will be allocated tothe recently-acquired Mindbalanced Inc. ( “ MB”) operations (NDAT acquired 100% of MB onApril 16, 2024). The remainder will be used for general workingcapital. There are no warrants or rights attached to the Shares andthe Shares will be subject to a minimum four month hold period.
For Further Information about thistransaction, please contact:
James Durward, CEO&CTO
Email: jimd@ndatalyze.com
nDatalyze Website: https://www.ndatalyze.com
YMI Website: https://ymihealth.ca
About Mindbalanced, Inc.: Mindbalanced’s vision is to redefine mentalhealthcare through an integrative, personalized approach leveragingcutting edge technology and non-invasive treatment protocols. Byharnessing evidence-based data we aim to predict and enhance mentalwellbeing, taking into account individual predispositions andenvironmental factors thereby fostering healthier and more fulfillinglives for all.
About YMI: YMIuses evidence-based, objective data from whole life experiences topredict individual mental states over time and applies this knowledgetowards a fuller understanding of how mental health develops, and howto improve mental wellbeing. YMI combines supervised machine-learningwith a proprietary Reference Database to predict an individual’spredisposition toward a variety of common mental conditions, bothcurrent and forward in time. YMI is poised to revolutionizemental health diagnoses while ensuring a sustainable revenue stream.By strategically addressing the causes of misdiagnosis, establishingcredibility through clinical studies, and targeting key markets, YMIaligns both societal impact and financial success.
Neither the Canadian Securities Exchange nor itsRegulation Services Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release. This news release does notconstitute an offer to sell or a solicitation of an offer to sell anyof the securities in the United States. The securities have not beenand will not be registered under the United States Securities Act of1933, as amended (the "U.S. Securities Act") or any statesecurities laws and may not be offered or sold within the UnitedStates or to U.S. Persons unless registered under the U.S. SecuritiesAct and applicable state securities laws or an exemption from suchregistration is available. The information in this news releaseincludes certain information and statements about management's view offuture events, expectations, plans and prospects that constituteforward looking statements. These statements are based uponassumptions that are subject to significant risks and uncertainties.Because of these risks and uncertainties and as a result of a varietyof factors, the actual results, expectations, achievements orperformance may differ materially from those anticipated and indicatedby these forward-looking statements. Any number of factors could causeactual results to differ materially from these forward-lookingstatements as well as future results. Although the Corporationbelieves that the expectations reflected in forward looking statementsare reasonable, it can give no assurances that the expectations of anyforward-looking statements will prove to be correct. Except asrequired by law, the Corporation disclaims any intention and assumesno obligation to update or revise any forward-looking statements toreflect actual results, whether as a result of new information, futureevents, changes in assumptions, changes in factors affecting suchforward-looking statements or otherwise.
Copyright (c) 2024 TheNewswire - All rights reserved.